Debates
- Features
- Topics
  Upcoming debates
- Close ✕
  - Prescription Weight Loss…
    
    A new study from The Lancet revealed that three-quarters of U.S. adults and almost half of teens are now overweight or obese. Weight loss drugs like Ozempic, Wegovy, and Mounjaro, known as GLP-1 drugs, have been making headlines as effective treatments that are in high demand. But should they be available to anyone who wants them or only when medically indicated? Those who believe they should be broadly available say they can increase self-esteem and are an important tool for those unable to lose weight through lifestyle changes alone. They also say they may reduce the risks of diabetes, heart disease, and joint issues and point to new research that suggests the drugs might help with improving cardiovascular and brain health and reduce the risk of conditions such as Alzheimer’s disease. Others argue that weight loss drugs are not right for everyone and caution against liberal access, citing both known side effects and unknown long-term effects. They also worry about what could happen if people take them without medical supervision and raise equity issues, given the high cost of the drugs. With this background, we debate whether prescription weight loss drugs should be available for all.
    
    Friday, January 24, 2025
Insights
About
- - Become a Member
  - Newsletter
- Close ✕
  
  SUPPORT OPEN-MINDED DEBATE
  
  Help us bring debate to communities and classrooms across the nation.
  Donate
Header Bottom
- Become a member Newsletter Donate

Obama's Jobs Bill: Read It and Weep

Tuesday, September 27, 2011

By Richard Epstein

The dim news about the current economic situation has prompted the Obama administration to put forward its latest, desperate effort to reverse the tide by urging passage of The American Jobs Act (AJA), a turgid 155-page bill.

Link to Article
Article source: Hoover Digest

Upcoming Debates

Prescription Weight Loss Drugs for All?

With David Allison, Stuart W. Flint

10:00 AM | Friday, January 24, 2025

A new study from The Lancet revealed that three-quarters of U.S. adults and almost half of teens are now overweight or obese. Weight loss drugs like Ozempic, Wegovy, and Mounjaro, known as GLP-1 drugs, have been making headlines as effective treatments that are in high demand. But should they be available to anyone who wants them or only when medically indicated? Those who believe they should be broadly available say they can increase self-esteem and are an important tool for those unable to lose…

Prescription Weight Loss Drugs for All?

With David Allison, Stuart W. Flint

10:00 AM | Friday, January 24, 2025

The Hopkins Forum: A Debate on the Future of the Supreme Court

With Ambassador Jeff Flake, Jamal Greene, Cristina Rodríguez, The Honorable Jeff Sessions

6:30 PM | Wednesday, January 29, 2025

Attend Event

The Hopkins Forum, a new nonpartisan debate series from Johns Hopkins University and Open to Debate, is hosting its first debate and taking a close look at the highest court in the land and its future. In the past year, multiple proposals have been suggested to change the way the Supreme Court operates. While the Justices enjoy lifetime tenure, term limits have been discussed in policy circles as a way to bring fresh and diverse perspectives to the bench. Others have suggested similar objectives might be achieved…